<?xml version="1.0" encoding="UTF-8"?>
<p>COVID-19 emerged in China at the end of 2019 spreading rapidly to infect over 213 countries and territories worldwide resulting in more than 11 500 000 confirmed cases and 500 000 deaths as of 6th July 2020 [
 <xref rid="R3" ref-type="bibr">3</xref>]. While it has been realized that patients with chronic conditions require additional health support to mitigate risk of COVID-19, it is also important to recognise the vulnerability of chronically-ill migrant populations whose health issues are often neglected [
 <xref rid="R2" ref-type="bibr">2</xref>]. This is especially of concern in HIV/AIDS-infected migrant populations who avoid deportation and are considered illegal as immigration laws in various countries do not permit carriers of HIV infection to work or stay regardless of their legal status [
 <xref rid="R4" ref-type="bibr">4</xref>,
 <xref rid="R5" ref-type="bibr">5</xref>]. Reports have confirmed that Russia, Middle-East and South-East Asian countries usually deport migrant workers who test positive for HIV [
 <xref rid="R6" ref-type="bibr">6</xref>]. Reports have confirmed that until 2014, approximately 51 000 HIV-positive patients have been deported back to Pakistan from the Gulf countries [
 <xref rid="R7" ref-type="bibr">7</xref>]. In a bid to escape deportation, these HIV positive migrants are often forced to obtain antiretroviral therapy (ART) illegally through exploitation of informal channels, friends or family to continue treating their condition [
 <xref rid="R6" ref-type="bibr">6</xref>,
 <xref rid="R8" ref-type="bibr">8</xref>]. In other cases, these migrants are forced to buy expensively priced drugs (or in desperation, share the highly sought treatment with other migrants in order to afford it) [
 <xref rid="R8" ref-type="bibr">8</xref>].
</p>
